|
|||||
|
|
Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis |
|
| Authors: | L. Cummins V. S. Katikireddi S. Shankaranarayana K. Y. C. Su E. Duggan V. Videm H. Pahau R. Thomas |
| Affiliation: | 1. University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia;2. Princess Alexandra Hospital, Brisbane, Queensland, Australia;3. Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway;4. Department of Immunology and Transfusion Medicine, St Olav University Hospital, Trondheim, Norway |
| Abstract: | |
| Keywords: | rheumatoid arthritis anti‐rheumatic agents medication persistence |